Board of Directors
Ben Chien - Chairman ＆CEO
Legal Representative of Foresee Pharmaceuticals, Inc.
Education：
Ph.D. in Analytical Chemistry, University of Michigan
Professional background：
DuPont Merck Pharmaceuticals, Inc.
Co-founder of Theracor Pharmaceuticals, Inc.
Chairman and CEO of QPS Holdings, LLC
Board Member of Delaware Bioscience Association
Consultant of Chinese Bioscience Association, Bay Area, San Francisco
Current position：
Chairman and CEO, Foresee Pharmaceuticals Co., Ltd.
Director of Foresee Pharmaceuticals USA, Inc.
Director of Foresee Pharmaceuticals Canada, Inc.
Chairman of Foresee Pharmaceuticals, Inc.
Member of Foresee Pharmaceuticals, LLC
Chairman of QPS Holding, LLC
Director of QPS Group Holdings, LLC
Member of QPS, LLC
Member of BKCA, LLC
Member of QPS MRA, LLC
Director of XDD Acquisition B.V.
Director of QPS Austria GmbH
Director of QPS Netherlands B.V.
Director of QPS Bioserve India Pvt. Ltd.
Chairman of QPS Taiwan
Chairman of Qualitix Clinical Research
Chairman of Unitix Clinical Research Co., Ltd.
Executive Director / President of Kuale Tisi (Shanghai) Medical Company Information Consultation Co., Ltd.
Executive Director of QPS Shanghai Co., Ltd.
Vincent Yen – Director
Legal Representative of Foresee Pharmaceuticals, Inc.
Education：
MBA, Fu Jen Catholic University
Professional background：
Unilever (China) Regional Manager
Gillette (Taiwan) Director
QPS Regional GM of Asia
Current position：
Member of QPS Holding, LLC
Member of QPS, LLC
Member of BKCA, LLC
Member of QPS MRA, LLC
Director of QPS Bioserve India Pvt. Ltd.
Director and President of QPS Taiwan
Director and President of Qualitix Clinical Research
Director of Unitix Clinical Research Co., Ltd.
President of QPS Shanghai Co., Ltd.
Yisheng Lee – Director
Legal Representative of Foresee Pharmaceuticals, Inc.
Education：
Ph.D. in Cancer Immunology / Pathology, Duke University
Professional background：
Assistant professor at Stanford University
Associate Clinical Professor at University of California, San Francisco
Current position：
Director and Chief Medical Officer, Foresee Pharmaceuticals Co., Ltd.
Director of Foresee Pharmaceuticals, Inc.
Director of ForeSee Pharmaceutical LLC
Director of QPS (Quest Pharmaceutical Service) Inc.
Member of QPS Holding, LLC
Director of QPS Group Holdings, LLC
Member of QPS, LLC
Member of BKCA, LLC
Member of QPS MRA, LLC
Director of QPS Taiwan
Member of BioQuiddity Incorporated, Medical Advisory Board
Attending physician of Pediatric Hematology/Oncology, Northern California Children’s Hematology & Oncology Program
George Jia-Long Lee – Director
Education：
Ph.D. in Chemistry, New York State University
Professional background：
R&D Manager of Syntex
Chairman of Epitomics
Current position：
Chairman of GenePharm Biotech Corp
Chairman of SunWay Biotech Co., Ltd.
Chairman of Applied Biocode Taiwan Ltd.
Chairman of BioKey Inc.
Chairman of Genepharm, Inc.
Chairman of RevMAb, Inc.
Chairman of Applied Biocode Inc.
Director of BlossomHill Therapeutics, Inc.
Jeff Wang – Director
Education：
Ph.D. in Chemistry, University of Pittsburgh
Professional background：
CEO of Development Center for Biotechnology
Senior Researcher and Lead Researcher of DuPont and Merck & Co., Inc.
Post-doctoral research at Harvard University
Current position：
Independent Director of UniPharma Co., Ltd.
Director and President of BioGate Precision Medicine Corp.
Independent Director of Luminescence Technology Corp.
Fu-Shiow Yin – Independent Director
Education：
Ph.D. in Philosophy, University of Rochester
Professional background：
Technical Consultant at the Department of Industrial Technology, Ministry of Economic Affairs
Investment Evaluation Committee Member of Boston Life Science Venture Corp.
Independent Director of Pac-Link Bio Venture Capital Investment Corp.
Representative of Institutional Director, TaiGen Biotechnology Co., Ltd.
Director of Reber Genetics Co., Ltd.
Independent Director of PharmaEngine, Inc.
Current position：
Independent Director of EirGenix, Inc.
Hank Lai – Independent Director
Education：
Master of Business Administration, National Taipei University
Professional background：
Staff member, commissioner, auditor, section chief, senior auditor, deputy head at Securities and Futures Bureau, Financial Supervisory Commission
Senior secretary at Financial Supervisory Commission, Executive Yuan
Vice President of Motor Vehicle Accident Compensation Fund
Independent Director of PharmaEngine, Inc.
Independent Supervisor of TSH Biopharm
Independent Director of Yuanta Futures Co., Ltd.Current position：
Independent Director of Yuanta Securities Co., Ltd.
Independent Director of Excellence Optoelectronics Inc.
Frank Wen-Chi Lee – Independent Director
Education：
Ph.D. in Medical Chemistry, University of California, San Francisco
Professional background：
Millennium Pharmaceuticals, Inc. (The Takeda Oncology Company)
Director of New Pharmacokinetic Drug Research, Senior Director, Manager at Pharmacokinetics Division, Vice President of the Non-Clinical Development Department
Director of New Pharmacokinetic Drug Research, DuPont Pharmaceuticals Company
Research project manager, Glaxo Wellcome Inc.
Senior Research Researcher and Primary Scientific Researcher, Glaxo Inc.
Senior chemist of pharmacokinetics, Syntex Research Institute
Current position：
Director and Chief Strategy Officer of BRIM Biotechnology, Inc.
FWL Consulting Services, LLC Principle
Co-founder of Chinese Entrepreneur Association (non-profit organization)